Abstract. VLA-2 (also called gpla/IIa on platelets) is a collagen receptor with a unique ot subunit and a subunit common to other adhesion receptors in the VLA/integrin family. Multiple cDNA clones for the human VLA-2 o~ 2 subunit have been selected from a hgtll library by specific antibody screening. The 5,374-bp nucleotide sequence encoded for 1,181 amino acids, including a signal peptide of 29 amino acids followed by a long extracellular domain (1,103 amino acids), a transmembrane domain, and a short cytoplasmic segment (22 amino acids). Direct sequencing of purified ot z protein confirmed the identity of the 15 NH2-terminal amino acids. Overall, the ot 2 amino acid sequence was 18-25% similar to the sequences known for other integrin ot subunits. In particular, the a2 sequence matched other integrin c~ chains in (a) the positions of 17 of its 20 cysteine residues; (b) the presence of three metal-binding domains of the general structure DXDXDGXXD; and (c) the transmembrane domain sequence. In addition, the ot 2 sequence has a 191-amino acid insert (called the 1-domain), previously found only in leukocyte integrins of the 82 integrin family. The oe 2 I-domain was 23-41% similar to domains in cartilage matrix protein and von Willebrand factor, which are perhaps associated with collagen binding. The NH2-terminal sequence reported here for c~ 2 does not match the previously reported o~ 2 NH2-terminal sequence (Takada, Y., J. L. Strominger, and M. E. Hemler. 1987. Proc. Natl. Acad. Sci. USA. 84:3239-3243). Resolution of this discrepancy suggests that there may be another VLA heterodimer that resembles VLA-2 in size but has a different amino acid sequence.
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V LA-2
is an c~/~/-subunit cell surface heterodimer strongly implicated as receptor for collagen because (a) VLA-2 has been shown to be identical (61) to a 150,000/ll0,000-Mr structure recognized by the mAb P1H5, which specifically blocks human fibrosarcoma cell (66) and platelet (31) attachment to collagen; (b) patients deficient in platelet protein Ia (or subunit of VLA-2) also lacked responsiveness to collagen (27, 41) ; and (c) the mAb 12F1 was used to identify VLA-2 as a 160,000/130,000-Mr (nonreduced) platelet protein complex that mediates Mg2+-dependent adhesion to collagen (51, 52) . Also in this regard, antigens that strongly resemble VLA-2 in size have been implicated in hepatocyte cell attachment to type I collagen (14) .
The cell surface heterodimer VLA-2 was initially characterized as a "very late antigen" appearing on activated T cells (19, 20) . Later the mAb 12F1 was used to identify VLA-2 on platelets and on many other cell types, including most rapidly growing, adherent cell lines (43) . Major portions of the platelet gpla and IIa are probably the same as the VLA-2 Y. Takada is currently at Biochemistry Division, National Cancer Center Research Institute, 1-1, Tsukiji, 5-chome, Chuo-ku Tokyo, 104 Japan. c~ and/3 subunits, respectively (31, 44) . Thus the new platelet-specific alloantigens Br ~ and Br b, which reside on the platelet Ia-IIa complex (53) , may be variable epitopes on VLA-2.
In other studies, an antibody (called 5E8) that recognizes VLA-2 (Hemler, M., and C. Crouse, unpublished results) has been described on most primary human lung tumors (68) , and ~25I-coupled 5E8 antibody has been used to inhibit the growth of lung tumor cell lines in vitro (57) .
The expression of VLA-2 can be up regulated on lymphocytes in response to mitogen or antigen stimulation (17) and on fibroblasts in response to serum (10) . Conversely, VLA-2 expression slowly diminished when those stimuli were withdrawn and/or cells became quiescent (10, 17) . Also, VLA-2 expression can be up regulated by TGF/~ (15) .
Like other cell surface receptors for extracellular matrix components, VLA-2 belongs to the integrin superfamily (26, 49) . Three subfamilies of that superfamily that are defined for humans are (a) the six (or more) VLA proteins (16, 23) ; (b) the leukocyte adhesion molecules, LFA-1, Mac-l, and p150,95 (56) ; and (c) the cytoadhesins, which include the vitronectin receptor and platelet gplIb/IIIa (13) . Within each family, the member heterodimers are each composed of a unique ot subunit associated with a common 13 subunit. Analyses of human eDNA clones for the/3 subunits of each subfamily (called 13, 135 , and/33, respectively) have revealed that they are 44-47% similar (2, 12, 28, 33, 62) , suggesting a common evolutionary origin. The evolutionary conservation of/3t is emphasized by the homology (82-86%) mainmined between/$~s from widely diverging species, such as human, chicken, and frog (9) , and 45 % homology between human /3, and a /31-like structure from Drosophila (36) .
Also, complete sequencing of several integrin ot subunitsincluding those from a fibronectin receptor (or 5) (2, 11), the vitronectin receptor (58) , platelet gplIb/IIIa (11, 45), Mac-1 (3, 8, 46) , p150,95 (7) , and the Drosophila PS2 antigen (6)-have revealed 20-60% similarity between any pair. Some of these integrin structures are receptors for ligands containing the amino acid signal sequence Arg-Gly-Asp (RGD) or a closely related sequence (49) . Although NH2-terminal amino acid sequencing has suggested ,o40% shared residues among six different VLA ot subunits (24, 60) , complete sequence information is available for only one VLA ot subunit (or 5) (2, 11). Thus, to further establish patterns of similarity and differences among VLA/integrin sequences and to gain basic information for future studies of structure, function, and regulation, the complete sequence of the VLA ot 2 subunit was obtained. Also, because the ot2-subunit NH2-terminal sequence predicted from cDNA did not match the previously published "or 2" NH2-terminal sequence, experiments were carried out to resolve this discrepancy.
Materials and Methods

Purification of VLA-2 from Platelets and
NHz-terminal Sequencing
VLA-2 protein was purified from outdated platelets (from the Dana-Farber Cancer Institute [Boston, MA] blood bank or from the American Red Cross [Dedham, MAD by lectin-Sepharose and then by 12FI or A-1A5 immunoaffinity chromatography (60) . The anti-~ 2 mAb 12F1 (43) and the anti-~ mAb A-IA5 (18) were obtained as described. For NH2-terminal amino acid mierosequencing of the 62 subunit, the ~2 subunit was first separated from the/ff subunit by SDS-gel electrophoresis, transferred to a polyvinylidene difluoride membrane (Immobilon; Millipore Continental Water Systems, Bedford, MA), stained with Coomassie blue, and destained as described (39) . Excised membrane pieces containing 62 material were then sequenced using a gas-phase sequenator (470A; Applied Biosystem, Inc., Foster City, CA) equipped with a phenylhydantoin amino acid analyzer (120A; Harvard Microsequeneing Facility, Cambridge, MA).
Preparation of aZ-Subunit-specific Antiserum
Subunits migrating in the o~ position (,050 #g from A-IAS-Sepharose or 12FI-Sepharose) were reduced and separated using preparative 5% SDS-PAGE, stained with Coomasie blue, and destained in 7 % acetic acid and 30% methanol. The band corresponding to a2 peptide was cut out and electroeluted into Tris/glycine/SDS buffer using an Elutrap (Schleicher & SehueU, Inc., Keene, NH). The eluted peptide was used for rabbit immunization as previously described (23) . Also, 62 protein purified from 12F1-Sepharose was used for immobilization onto CNBr-Sepharose (Pharmacia Fine Chemicals, Piseataway, N J) according to the manufacturer's instructions, except that 0.1% of SDS was included in the coupling buffer. Antibodies from rabbit anti-a2-subunit antiserum were then purified using the 62-Sepharose affinity column. Briefly, the antiserum was passed through the column several times and the column was washed successively with 3 column volumes each of PBST (0.14 M NaCI, 10 mM sodium phosphate, 0.2% Tween 20), 0.2 M KSCN, and then PBST again. For elution of 62-subunit-specific IgG, 3 M KSCN was added, and the eluate was desalted by Sephadex G-25 chromatography into PBST in the presence of 0.1% hemoglobin as carrier. Immunopurified IgG was further incubated with denatured Escherichia coil protein coupled to Sepharose, and with glycoprote, ins from Molt-4 cells coupled to Sepharose to remove additional nonspecific reactivity. The Molt-4 leukemic T cell line does not usually express VLA-2 (22) .
Production of Antibodies to an ~2 COOH-terminal Synthetic Peptide
A 22-mer consisting of the COOH-terminal 21 amino acids predicted from the c~ 2 sequence, with an added cysteine at the NH2-terminal end of the peptide, was synthesized by Multiple Peptide Systems (San Diego, CA). This peptide was coupled to carrier protein (keyhole limpet hemocyanin) using m-maleimidobenzoyl-N-hydroxysulfosuccinimide ester (Pierce Chemical Co., Rockford, IL) as previously described (29) , and then rabbit antibodies were generated using standard techniques (38) .
Isolation of the Gene Encoding the ~2 Subunit
A phage ),gill expression eDNA library of human lung fibroblast IMR-90 (CIontech Laboratories, Inc., Palo Alto, CA) was screened by using afffinitypurified rabbit antibodies against 62 subunit according to Young and Davis (67) , except that alkaline phosphatase-conjugated anti-rabbit IgG was used as a second antibody. Alkaline phosphatase activity was detected by using an immunoscreening system (ProtoBlot; Promega Biotec, Madison, WI) with nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate as substrates. Positive clones from the screening were plaque purified, and then phage DNAs were purified by the plate lysate method (37) . After the insert was excised from the phage by Eco RI restriction enzyme digestion, the inserts were separated On agarose gels, electroeluted, and subcloned into pBluescript plasmid (Stratagene, La Jolla, CA). A eDNA library made in kgtll from endothelial cells was the kind gift from Dr. Tucker Collins (Brigham and Women's Hospital, Boston, MA).
DNA Sequencing
The DNA sequences were determined by the dideoxynucleotide chain-termination method of Sanger et al. (50) using adenosine 35S-5'-[ct-thio]triphosphate. To facilitate complete sequencing of both eDNA strands, a series of overlapping deletion clones were made in both directions as described (25) by using the Erase-a-base system (Promega Biotec).
Other Techniques
Southern blot analysis was carried out as described (37) . For Northern blot analysis, 5 #g of each RNA sample was eleetrophoretically separated on 1% agarose gels in buffer containing formaldehyde, transferred to nylon membrane (Nytran; Schleieher & Schuell) (37) , and then probed with a nicktranslated 5.4-kb 62-subunit cDNA (in pBluescript) using standard hybridization techniques (37) . Western blotting (63) and immunoprecipitation (22) were performed as previously described.
Results and Discussion
Cloning of cDNA with a2-Subunit-specific Antibody as Probe
Affinity-purified rabbit anti-c~ ~ antiserum was tested by immunoblotting of whole platelet lysate and found to bind specifically to platelet VLA a s subunit (Fig. 1) , thus affirming the suitability of the serum for library screening. The affinity-purified antibody was then used for immunoselection of clones from a phage Xgtll expression eDNA library made from human lung fibroblast (IMR-90) since fibroblasts were known to be good source for ~2 protein (21). After subcloning into plasmid, a representative positive clone (clone 2.38, ,,ol.2 kb) was directly sequenced and found to have partial homology to known sequences of other ot subunits in the integrin superfamily. Subsequently, clone 2.38 was used to probe a human endothelial cell ~,gtll library (another good source for ot 2 expression) since that library had longer inserts. Thus, another clone was selected (clone 2.72, ,,o5.4 kb), completely sequenced, and found to include all of the coding region and cenfly described multiple forms of platelet gpIa (5) bear any relation to the two distinct NH2-terminal sequences described here. Figure 1 . Immunoblotting analysis of rabbit antibody after enrichment for ~ specificity. After SDS-PAGE separation of purified platelet VLA proteins, the proteins were blotted onto nitrocellulose and then incubated with rabbit anti-/3~ (lane a) or anti-~ purified (see Materials and Methods) rabbit antiserum (lane b). Bound primary antibody was located using ~2SI-labeled goat antirabbit second antibody. some of the 3' and 5' untranslated regions (Fig. 2) . Notably, the sequence of clone 2.38 (from a fibroblast library) was identical to the corresponding region in clone 2.72 (from an endothelial cell library).
Comparison of Clone 2.72 cDNA Sequence with ~z. Subunit NHrterminal Protein Sequence
Surprisingly, the previously published 03 NH2-terminal sequence FNLDTEXDNVFRGP (Fig. 3 A) only partly resembled the 03 NH2-terminal sequence YNVGLPEAKIFSGPS encoded by eDNA (Fig. 3 C) , with homology in only 5 of the 14 positions. To resolve this discrepancy, additional NH2-terminal amino acid sequencing was carded out. Using mAb 12F1-Sepharose, VLA-2 material was purified either from platelets or placenta. After preparative SDS-PAGE, highly purified 03 subunit from either source yielded an NH2-termihal amino acid sequence of YNVGLPEAKIFSGPS (Fig. 3  D) , identical to the sequence encoded from eDNA ( Fig. 3 C) . In another experiment, VLA proteins were purified from 25 g of platelets using the anti-/3 mAb A-IA5, and the resulting mixture of subunits was then separated by reducing SDS-PAGE so that ~x 5 and ol 6 subunits would migrate at 130,000 M,, away from the 160,000-M, oF subunit (23) . Upon NH2-terminal amino acid sequencing of the purified B~-associated 160,000-M~ 03-like protein from the reduced gel, a mixture of the YNVGLPEAKIFS and FNLTDXEDNVFR sequences was present, with approximately equivalent molar ratios (Fig.  3 B) . Thus, it appears that the latter sequence may belong to a protein of 160,000 Mr that is distinct from 03, though it closely resembles oe 2 in size. At present, nothing else is known about this potentially new subunit, other than it appears to coprecipitate with /3l (when using the anti-Bt mAb A-1AS). Because the mAb 12F1 (originally used to define VLA-2 [43] ) was used to isolate the protein with the YNVGLPEAKIFS... sequence, that protein merits the designation as the authentic o~ 2. It remains to be seen if the re-
Northern Blotting Analysis
The distribution of mRNA for the a 2 subunit was studied by Northern blotting with eDNA clone 2.72 as the probe. A single band at '~8 kb was detected in fibroblast RNA, whereas little or no signal at the same position was obtained in HSB or Molt-4 T cell lines (Fig. 4) . These results are consistent with the known cell surface expression of VLA-2 on these cells (21, 22) . Hybridization of the same blot with a cDNA probe for the human actin gene gave comparable signals in all lanes. Since the RNA size (8 kb) was somewhat larger than the eDNA clone (5.4 kb) and since no poly A tail is present (Fig. 2) , it is assumed that the 3' untranslated region (and perhaps also the 5' end) is incomplete.
Authenticity of the ~2 Clone
Despite the unexpected NH:-terminal sequence results, the 03 clone obtained is authentic because (a) the eDNA was selected using antibodies specific for the 03 subunit; (b) the NH2 terminus of the predicted sequence was identical to that directly determined from purified 03-subunit protein; (c) the mRNA distribution agrees with that of the mature protein; (d) the size of the predicted protein closely agrees with the experimental value (see below); (e) the predicted sequence has several features characteristic of other integrin tx subunits (see below); and (f) native 03 protein could be readily immunoprecipitated by antisera prepared against a synthetic COOH-terminal peptide including 21 amino acids deduced from the 03 cDNA sequence (Fig. 5 ).
As shown in Fig. 5 A, rabbit serum directed against an 03 COOH-terminal synthetic peptide (predicted from cDNA sequence) recognized an oeB complex (lane c) from the colon carcinoma cell line CCL-228 that closely resembled VLA-2 (lane b). Prior removal of all material seen by the rabbit serum (lane f ) resulted in the simultaneous removal of VLA-2 (lane e), but only partially diminished total VLA as seen by mAb A-1A5 (cf. lanes a and d). Also, anti-03 COOH-terminal peptide sera specifically immunoblotted tx 2 purified from platelets using either the mAb A-1A5 ( Fig. 5 B, lane a) or 12F1 (lane b). In comparison, serum from a rabbit immunized with isolated tx 2 protein (before anti-03 antibodies were purified) recognized mostly a 2 (but also fl~) in preparations obtained from platelets using A-IA5 (lane c) or 12FI (lane d), whereas a negative control serum did not blot any detectable purified platelet protein (lanes e and f).
Amino Acid Sequence of the ~2 Subunit
Translation of the eDNA sequence of clone 2.72 ( Fig. 2 ) yielded coding sequences of 3,543 bp (encoding 1,181 amino acids) between the 3' and 5' untranslated portions of ~50 bp and 1,800 bp, respectively. Preceding the NH~-terminal sequence of the mature protein (YNVGLPE...) is a translational start site (30) that codes for a methionine followed by 29 amino acids, fulfilling the requirements for a signal peptide (64) . Thus, the open reading frame shown in Fig. 2 126,000 Mr. The addition of 10 potential N-glycosylation sequences (Asn-Xaa-Ser/Thr, average 2,500 Mr) to the core protein would result in an estimated molecular mass of 151,000 D. That value is close to the 155,000-160,000 Mr estimated from u2-subunit migration on SDS-polyacrylamide gels. Analysis of the NH2-terminal portion of the sequence revealed the presence of seven homologous repeating domains (Fig. 6 ). These domains contain 28-41 amino acids and are 20-30% similar to each other. Also, these domains are spaced 23-32 amino acids apart, except that there is a large additionally inserted "I-domain" of 191 amino acids (see below) between repeating domains II and III. /N)xD(G)xxD (Fig. 2, small boxes, and  Fig. 6, underline) that are somewhat similar to the EF-hand consensus metal-binding domains of a number of calciumand magnesium-binding proteins, including calmodulin, troponin C, parvalbumin (59), thrombospondin (34), myosin light chain (47) , and galactose-binding protein (65) . These potential divalent cation-binding sites in u ~ are located in a region (between amino acids 470 and 627) devoid of cysteine residues and N-glycosylation sites. The presence of divalent cation-binding sites in the a 2 subunit is consistent with divalent cation requirements for the function of VLA-2 as a human collagen receptor (51, 52) .
Comparison of &-Subunit Sequence with Other lntegrin ~ Chains
The alignment of the o?-subunit sequence with the u-chain sequences of human fibronectin receptor (VLA-5), vitronectin receptor, gplIb/IIIa, Mac-l, and p150,95 shows that several structural characteristics are shared (Fig. 7) . For example, of the 20 u2-cysteine residues, 17 are conserved in at least three of the other sequences and 14 are conserved in all six u-subunit sequences. Also, there is 32-45 % conservation in the 22-amino acid transmembrane region and 100% conservation of the GFFKR sequence on the cytoplasmic side of transmembrane domain. Additional striking similarities are evident in the region of the a 2 homologous repeats in the NH2-terminal half of the molecule. Like a 2, each of the other integrin u subunits has also been noted to have seven homologous repeats, with three or four potential divalent cation sites within repeats IV-VII (2, 3, 7, 8, 11, 45, 46, 58) . In these repeat regions, the average similarity between u 2 and the other u subunits ranged from 30-38% (repeats I, II, III, and VII) to 46-52 % (repeats IV, V, and VI). The overall similarity between u 2 and the other integrin a subunits is 18-25%, or 22-24% if the 1-domain (see below) is excluded. This is in contrast to the higher degree of identity (~45%) between different human integrin fl chains (2, 12, 28, 33, 62) .
Comparison of the a2-Subunit 1-Domain with Similar Domains in Other Proteins
In studies of Mac-1 (3, 8, 46) , p150,95 (7), and LFA-I (32), an inserted domain of '~200 amino acids was found that is not present in the u 5, u v, or IIb chains. In those studies, the inserted I-domain (32) (formerly called the L-domain) was noted to resemble the von Willebrand factor (vWF)' AI, A2, and A3 domains, cartilage matrix protein (CMP)-t and CMP-2 domains, and domains in complement factors B and C2. Now an I-domain has also been discovered in the u 2 sequence. The sequence of the c~ 2 1-domain is aligned with other related domains as shown in Fig. 8 , and percent similarity calculations from those data were used in the construction of the linkage tree shown in Fig. 9 . The u 2 1-domain sequence (allowing for conservative amino acid substitutions) most resembled I-domains from p150 (48%) and Mac-I (45%) and also resembled the CMP-1 (46%) and CMP-2 (44 %) domains. Less similarity was seen with vWF domains The vWF protein contains at least two independent collagen-binding sites, localized to the A1 and A3 domains (42, 48) and, likewise, CMP-1 and CMP-2 domains may be used to mediate interaction with collagen (1). Because VLA-2, vWE and CMP all share related domains and can interact with collagen, that suggests the I-domain may be important for adhesion to collagen. However, the presence of an 1-domain (or related sequence) does not completely correlate with a collagen adhesion function since there is no evidence that p150,95 or Mac-1 interact with collagen and, likewise, complement factors B and C2 are not known to bind collagen.
Grouping of lntegrin ~ Subunits into Subsets
From sequence analysis, together with earlier data, it is clear that there are several structural features that distinguish integrin ct subunits containing I-domains from those that do not (Table I) . It has previously been noted that the mature forms of integrin c~ subunits t~ s, a v, and lib each contain a cleaved peptide fragment (the COOH-terminal 15 % of the protein) that is attached to the rest of the subunit by a disulfide linkage. Consistent with this, dibasic protease cleavage sites have been noted in the appropriate locations in each of those sequences (2, 35, 58) . Notably (Table I) , the subunits with I-domains (~2, c~M, and p150) do not undergo protease cleavage, whereas the cleaved subunits do not have I-domains. In this regard, in the region where protease cleavage occurs for t~5, ~v, and lib, the three I-domain subunits have gaps of 20 or more amino acids and no dibasic amino acids (see Fig.  7, a 2 position 1,018) . mAbs 12FI and A-1A5 were used to purify either VLA-2 or total VLA protein from platelets (see Materials and Methods). Then aliquots of purified proteins were separated by SDS-PAGE, blotted onto nitrocellulose, and probed as described (63) using rabbit antiintact ot 2 plus B~ (lanes a and b) , anti-COOH-terminal synthetic peptide (lanes c and d) , or control rabbit serum (lanes e and f). 
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Not only are there differences in the number of divalent cation sites, but evidence also suggests that the two groups of integrin a subunits may each have their own characteristic intrachain disulfide loops. Analysis of cysteines (Fig. 7) reveals that the majority (14 cysteines) are conserved throughout all six integrin ct-subunit sequences. However (Table I ), Figure 9 . Linkages between cG-subunit I-domains and similar domains in other proteins. Based on the alignment in Fig. 8 , percent similarities were calculated (allowing for conserved amino acids as defined in Fig. 6 ), and then linkage trees were determined by standard procedures using the average linkage values (55) . Similar determinations, not allowing for conserved amino acids (based on percent identical amino acids only), yielded similar results except that ct 2 clustered with CMP-1 and CMP-2 instead of a M and p150. Table I with respect to potential divalent cation sites and conserved cysteine residues. Structural information for the Drosophila PS2 ct subunit (6) is also included in Table I . Although the source is phylogenically far removed from humans, the properties of that ct subunit are fully consistent with the properties of the other cleaved ot subunits. In addition to the "group-specific" cysteine residues mentioned in Table I , there are many other amino acids at posi- tions throughout the aligned sequences that distinguish I-domain integrins from cleaved integrins. In fact, when the aligned sequences (Fig. 7) were searched by computer to find all positions in which exactly three sequences had identical amino acids, this was found to occur most often (at 99 positions) among the set o:, IIb, and ctv and also occurred often (at 64 positions) among the set cd, p150, and ot u (Table II, part A). Thus, the I-domain subunits could again be distinguished from the cleaved subunits, this time based on exclusively shared amino acids distributed throughout the coding region. Other sets of three subunits shared amino acids less frequently (at ~< 24 positions) and had no obvious structural similarities. Thus the results from the data in Table II , part A, support the conclusions drawn from Table I . Because the u 2 and o: subunits both associate with the same fl subunit (fl,), it might be assumed that these two sequences would show exclusive amino acid identity at several positions. However, when a computer search was performed (Table II , part B), positions with amino acid identity between only c~ 2 and c: were not very prevalent (seventh in the list of subunit pairs). In fact, ct 2 was more likely to share residues with lib or av than with 0:, and a 5 was more likely to share residues with o~ v or lib than with od. Thus, despite their common fl-subunit association, the ot 2 and a 5 subunits have relatively few amino acids common to only those sequences, making it difficult to predict potential o~-subunit sites that may be specific for fit interaction.
Summary
Cloning and sequencing of the ct 2 subunit of VLA-2 has revealed its complete primary structure, and confirmed its relatedness to other integrin c~ subunits. The presence of an ct 2 I-domain, which possibly participates in VLA-2 adhesion to collagen has been established, and comparative studies of the cd sequence have revealed that subunits containing I-domains have a number of additional structural features that distinguish them from cleaved integrin t~ subunits. Also, it is clear that fl-subunit use does not accurately predict the relative degree of similarity between integrin c~ subunits. For future studies, the results shown here will provide the basic information and materials needed for (a) additional structural comparisons with other integrins; (b) analysis of VLA-2 function through expression and mutagenesis; and (c) analysis of patient samples to measure deficient or mutated ct z.
